Jingxin Li

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Respiratory Syndrome Coronavirus

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Xu Han, Mingwei Wei, Xiuyu Zheng, Peng Wan, Jie Tang, Lu Zhang, Shupeng Zhang, Hanchi Zhou, Jiayu Lu, Li Zhou, Yawen Zhu, Jingxin Li, Fengcai Zhu
Immunogenicity, Safety, and Immune Persistence of One Dose of SARS-CoV-2 Recombinant Adenovirus Type-5 Vectored Vaccine in Children and Adolescents Aged 6-17 Years: An Immunobridging Trial. Vaccines 12 (6) (2024)
Xu Han, Mingwei Wei, Xiuyu Zheng, Peng Wan, Jie Tang, Lu Zhang, Shupeng Zhang, Hanchi Zhou, Jiayu Lu, Li Zhou, Yawen Zhu, Jingxin Li, Fengcai Zhu
Immunogenicity, Safety, and Immune Persistence of One Dose of SARS-CoV-2 Recombinant Adenovirus Type-5 Vectored Vaccine in Children and Adolescents Aged 6-17 Years: An Immunobridging Trial. Vaccines 12 (6) (2024)
Jiaqi Wang, Pengfei Jin, Hui Jin, Qiang Wang, Fengcai Zhu, Jingxin Li
Cost-Effectiveness Analysis of Herpes Zoster Vaccination in a Chinese Population: Recombinant Subunit Vaccine versus Live Attenuated Vaccine. Vaccines 12 (8) (2024)
Xu Han, Mingwei Wei, Xiuyu Zheng, Peng Wan, Jie Tang, Lu Zhang, Shupeng Zhang, Hanchi Zhou, Jiayu Lu, Li Zhou, Yawen Zhu, Jingxin Li, Fengcai Zhu
Immunogenicity, Safety, and Immune Persistence of One Dose of SARS-CoV-2 Recombinant Adenovirus Type-5 Vectored Vaccine in Children and Adolescents Aged 6-17 Years: An Immunobridging Trial. Vaccines 12 (6) (2024)
Pengfei Jin, Xiling Guo, Wei Chen, Shihua Ma, Hongxing Pan, Lianpan Dai, Pan Du, Lili Wang, Lai-Run Jin, Yin Chen, Fengjuan Shi, Jingxian Liu, Xiaoyu Xu, Yanan Zhang, George Fu Gao, Cancan Chen, Jialu Feng, Jingxin Li, Feng-Cai Zhu
Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccine (Convidecia/ZF2001): A randomized, observer-blinded, placebo-controlled trial. PLoS medicine 19 (5) (2022)